This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

ICONIC: Improving Carpediem Outcomes in Neonates and Infants Through Collaboration

Sponsored by Children's Hospital Medical Center, Cincinnati

About this trial

Last updated 3 years ago

Study ID

CIN001 - ICONIC

Status

Enrolling by invitation

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
All
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 4 years ago

What is this trial about?

To date, little knowledge exists related to the use of hemodialysis (HD) in infants and has been limited to mainly single center studies. The CARPEDIEM (CArdio-Renal PEdiatric Dialysis Emergency Machine) device, which can be used to provide hemodialysis in infants, has been launched in the United States. This study/registry is designed to obtain data on critically ill infants who require HD using the CARPEDIEM device to understand the indications for initiation, best practice in prescribing and performing treatment, expected treatment course, and outcomes of a dedicated infant continuous renal replacement therapy (CRRT) machine.

What are the participation requirements?

Yes

Inclusion Criteria

- Treated with CARPEDIEM as part of standard of care at a participating institution within the United States

No

Exclusion Criteria

- Parents/legally authorized representative unable or unwilling to provide consent

Locations

Location

Status